Live Chat

CFD:er är komplexa instrument som innebär hög risk att du förlorar pengar snabbt på grund av hävstången. 74,2% av icke-professionella investerares konton förlorar pengar när de handlar med CFD:er hos den här leverantören. Du bör överväga om du förstår hur CFD:er fungerar och om du har råd att ta den höga risken att förlora dina pengar.

Close

Affär Bristol Myers BMY

BristolMyers realtidsdiagram

Instrumentfundament

Weekly Search
Weekly
Daily
Datum Stäng Förändring Förändring (%) Öppna Hög Låg

Senaste nyheter

Forex candlestick chart of JPY/USD currency pair trends.
Vanessa L 2025 Jan 17, 10:00

Forex Prop Trading Updates and Income Levels' Impact on Forex

Forex JPY USD
Bitcoin price action is shown on a trading chart, with a British flag in the background.
Vanessa L 2025 Jan 17, 09:00

Bitcoin Price Action Muted: A Complete Guide on How to Buy Bitcoins in the UK

Cryptocurrencies
Frances Wang 2025 Jan 16, 16:00

S&P 500 and Nasdaq 100 Update: Strong Earnings Drive Market Gains

Indices
Frances Wang 2025 Jan 16, 16:00

Oil price today: Oil Prices Climb Amid Supply Fears

Oil
Frances Wang 2025 Jan 16, 16:00

Forex market update: GBP/USD, USD/JPY Forecast

Forex
Darius Anucauskas 2025 Jan 16, 16:00

Week Ahead: Japanese CPI and the BoJ rate hike on the watch, All eyes on the Canada inflation and Trump inauguration

The person silhouette with fluctuating red and green stock charts, symbolizes uncertainty.
Vanessa L 2025 Jan 16, 11:00

Why Is the Stock Market Going Down Today and Are Interest Rates Going Down?

Stocks Shares
A tanker carrying heating oil on a foggy morning, symbolizes the global energy trade.
Vanessa L 2025 Jan 16, 09:02

What Influences the Price of Heating Oil Per Gallon Today? Insights on Futures Contract Crude Oil

Oil Commodities

Info

Spread

0.35

Spread (%)

0.6230 %

Hävstångseffekt

1:5

Köp till dagslåneränta

-0.0597 %

Sälj till dagslåneränta

-0.0292 %

Valuta

USD

Handelstider

Marknaderna är stängda

Tisdag

14:31 - 20:59

Onsdag

14:31-20:59

Torsdag

14:31-20:59

Fredag

14:31-20:59

Analys och statistik

Öppna

---

Föregående stängning

---

52 veckors högsta/lägsta

--- – ---

Marknadsvärde

114348785664

Utelöpande aktier

2028179968

Rapportdatum (nästa)

2001-08-07

Utd-procent

2025-02-03

Datum efter utdelning

2025-01-03

Förväntad framtida årlig utdelningsprocent

2.48

Förväntad framtida årlig direktavkastning

0.0444

Vinst per aktie

-3.61

Läs mer om detta instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Läs mer om detta instrument

Tillgång
Sälj
Köp
Förändring (%)
Relaterade instrument
Trustpilot
Live Chat